Thank you for your hard work and dedication over the past year. I am looking forward to all that the upcoming 2017 year has in store for us.
Have a safe and enjoyable winter break.
CCTR Hosts Final Fall Brown Bag Seminar
Robert "Bobby" Moulden, manager
of Clinical Trials Management System for the VCU Wright CCTR, led a presentation with a particular focus on Online Collaborative Research Environment (OnCore), which is a Clinical Trials Management System (CTMS) designed specifically for large academic medical centers with vibrant, expanding clinical research programs.
"OnCore helps coordinators work together on the most up-to-date forms and information," Moulden said. "It eliminates the need for teams to email files back and forth and provides a secure platform for materials containing patient health information."
1. Final technical reports for NIH will take the form of the federal standard "research performance progress report" also known as the "RPPR" currently used for annual progress reports.
2. NIH has long allowed for a submitted competing proposal to serve in lieu of a final report for a competitive segment. This practice will be discontinued. Final RPPR's (also referred to as "F-RPPR") will be due 120 days from the period of performance end date for all projects regardless of whether a competing continuation proposal is submitted. The F-RPPR will be treated as final if the competing is not funded. The F-RPPR will be treated as interim if the competing is funded.
Cite the Grant - CTSA award No. UL1TR000058
The VCU Wright Center for Clinical and Translational Research reminds investigators to please cite the CTSA grant, per requirement of the National Institutes of Health (NIH), if you receive funding through the VCU Wright CCTR or use any CTSA facility, services, or tools to support your research.
This includes the VCU Wright CCTR's Research
Innovator, grant writing assistance, Clinical Research Informatics (consultations, REDCap, i2b2), Clinical Research Services (clinical trials,
coordinator services), etc.